1Floyd JD, Nguyen DT, Lobins RL. Cardiotoxicity of cancer therapy. J Clin Oncol, 2005 ;23(30) :7685-7696.
2Kim SY, Kim S J, Kim B J, et al. Doxorubicin-induced reactive oxygen species generation and intraeellular Ca^2+ increase are reciprocally modulated in rat cardiomyocytes. Exp Mol Med, 2006 ; 38 ( 5 ) : 535-545.
3Nelson MA, Frishman WH, SeiterK, et al. Cardiovascular considerations with anthracycline use in patients with cancer. Heart Dis,2001 ;3 (3) :157-168.
5T jeerdsma GT, Meinardi MT, Graaf WTA, et al. Early detection of anthracycline-induced cardiotoxicity in asympomatie patients with normal left ventricular systolic function : autonomic versus echocardiographic variables. Heart,1999;81:419-423.
6Bu' Luck FA, Mott MG, Oakhill A, et al. Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function,sysptoms and pathophy siology. Br Heart J, 1995; 74( 3 ) :340-350.
9Adamcova M, Simunek T, Kaiserova H, et al. In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxity. Toxicology, 2007 ;237 (1-3) :218-228.
10Mir T S, Marohn S, Laer S, et al. Plasm concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive hertfailure. Pediatrics, 2002;110(6) :E76.
8Lang K, Borner A, Figulla HR. Comparison of biochemical markers for the detection of minimal myocardial injury: superior sensitivity of cardiac troponin-T ELISA.Robert HC and Hassan ME[J]. J Intern Med, 2000,247(1):119-123.
9Bulent Mutlu, Ahmet Yilmaz, Kenan Sonmez, et al Prognostic Importance of Predischarged Troponin T Levels in Acute Anterior Myocardial Infarction[J]. Jpn Heart J, 2004, 45: 43-52.
10Bholasingh R, Cornel JH, Kamp O, et al. The prognostic value of markers of inflammation in patients with troponin T-negative chest pain before discharge from the emergency department[J]. Am J Med, 2003,115(7):521-528.
10MinottiG,MennaP.SalvatorelliE,et al.Anthracyclines:molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity[J].Pharmacol Rev,2004,56(2):185-229.
